BECKY ROHNER: Open Payments
NPI 1134791635 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,021 in 39 payments from 16 companies in 2025. Trend: 2023 $920 · 2024 $1,673 · 2025 $1,021
Food & beverage: $1,021
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 2 | $161 |
| Merck Sharp & Dohme LLC | 7 | $127 |
| E.R. Squibb & Sons, L.L.C. | 7 | $124 |
| Novo Nordisk Inc | 1 | $119 |
| ABIOMED | 3 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Boston Scientific Corporation | 2 | $59 |
| Amgen Inc. | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $42 |
Products named: Assure WCD, VERQUVO, CAMZYOS, Ozempic, JARDIANCE, REPATHA, LEQVIO, LifeVest.
Industry payments across LA — which companies pay providers there.
